Investigational Site Number 250003

Besançon 25030

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Multiple Sclerosis Relapse

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early